Gene · 6580
Papers3,731
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,731
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas. | Sci Transl Med | 2021 | 34613815 | PubTator, text mining | PubMed |
| Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study. | CPT Pharmacometrics Syst Pharmacol | 2021 | 34608769 | PubTator, text mining | PubMed |
| Choroidal Thickness in Relation to Bone Mineral Density with Swept-Source Optical Coherence Tomography. | J Ophthalmol | 2021 | 34608419 | PubTator, text mining | PubMed |
| The Role of the Carnitine/Organic Cation Transporter Novel 2 in the Clinical Outcome of Patients With Locally Advanced Esophageal Carcinoma Treated With Oxaliplatin. | Front Pharmacol | 2021 | 34603016 | PubTator, text mining | PubMed |
| Organic Anion Transporting Polypeptide 2B1 (OATP2B1) Genetic Variants: In Vitro Functional Characterization and Association With Circulating Concentrations of Endogenous Substrates. | Front Pharmacol | 2021 | 34594217 | PubTator, text mining | PubMed |
| Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient. | Data Brief | 2021 | 34589561 | PubTator, text mining | PubMed |
| Genetic landscape of 125 pharmacogenes in Chinese from the Chinese Millionome Database. | Sci Rep | 2021 | 34584183 | PubTator, text mining | PubMed |
| Design, Synthesis, and Cytotoxicity Assessment of [64Cu]Cu-NOTA-Terpyridine Platinum Conjugate: A Novel Chemoradiotherapeutic Agent with Flexible Linker. | Nanomaterials (Basel) | 2021 | 34578470 | PubTator, text mining | PubMed |
| Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun Proteomics. | Viruses | 2021 | 34578337 | PubTator, text mining | PubMed |
| Potential and Limits of Kidney Cells for Evaluation of Renal Excretion. | Pharmaceuticals (Basel) | 2021 | 34577608 | PubTator, text mining | PubMed |
| Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation. | Molecules | 2021 | 34576971 | PubTator, text mining | PubMed |
| Expression Profiles of Circulating microRNAs in South African Type 2 Diabetic Individuals on Treatment. | Front Genet | 2021 | 34567065 | PubTator, text mining | PubMed |
| An Update in Our Understanding of the Relationships Between Gene Polymorphisms and Chemotherapy-Induced Nausea and Vomiting. | Int J Gen Med | 2021 | 34566427 | PubTator, text mining | PubMed |
| Author Correction: CKIP-1 limits foam cell formation and inhibits atherosclerosis by promoting degradation of Oct-1 by REGγ. | Nat Commun | 2021 | 34552081 | PubTator, text mining | PubMed |
Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level. | Drug Des Devel Ther | 2021 | 34548782 | PubTator, text mining | PubMed |
| Ontogeny of Small Intestinal Drug Transporters and Metabolizing Enzymes Based on Targeted Quantitative Proteomics. | Drug Metab Dispos | 2021 | 34548392 | PubTator, text mining | PubMed |
| Development of a novel SNP assay to detect lactase persistence associated genetic variants. | Mol Biol Rep | 2021 | 34515921 | PubTator, text mining | PubMed |
| Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma. | Cancers (Basel) | 2021 | 34503153 | PubTator, text mining | PubMed |
| Circulating microRNAs Signature for Predicting Response to GLP1-RA Therapy in Type 2 Diabetic Patients: A Pilot Study. | Int J Mol Sci | 2021 | 34502360 | PubTator, text mining | PubMed |
| Interactions of anti-COVID-19 drug candidates with hepatic transporters may cause liver toxicity and affect pharmacokinetics. | Sci Rep | 2021 | 34497279 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6580/papers?page=42